NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors: Effect on inositol lipid turnover

M. Ruggiero, S. K. Srivastava, T. P. Fleming, D. Ron, A. Eva

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We have examined polyphosphoinositide turnover in mouse fibroblasts (NIH3T3) transformed by the dbl oncogene as compared to normal cells. The dbl-transformed fibroblasts did not show alterations of the basal level of inositol polyphosphates, polyphosphoinositides, diacylglycerol or phosphatidic acid. This indicates that the activity of C-type phospholipases, inositol lipid kinases and diacylglycerol kinase is not altered in dbl-induced transformation. However, dbl-transformed NIH3T3 cells exhibited increased inositol lipid turnover in response to bradykinin. Further analysis revealed significantly higher number of bradykinin receptors in dbl transfectants as compared to control NIH3T3. When several clonally-derived dbl NIH3T3 transfectants were analyzed, we observed a large variation of their bradykinin receptor number. Cell lines exhibiting increased bradykinin binding, however, failed to show augmented mitogenic response to the peptide agonist. Among other oncogenes, only ras showed a similar effect. We conclude that increased bradykinin receptor number is a phenomenon observed with several cell lines transformed by different oncogenes, and it does not correlate with either enhanced mitogenic responsiveness of transformed cells to the peptide, or with the presence of a specific oncogene in the transformant.

Original languageEnglish
Pages (from-to)767-771
Number of pages5
JournalOncogene
Volume4
Issue number6
Publication statusPublished - 1989

Fingerprint

Bradykinin Receptors
Inositol
Oncogenes
Fibroblasts
Lipids
Phosphatidylinositol Phosphates
Bradykinin
Diacylglycerol Kinase
Polyphosphates
Peptides
Phosphatidic Acids
Transformed Cell Line
Diglycerides
Type C Phospholipases
Phosphotransferases
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors : Effect on inositol lipid turnover. / Ruggiero, M.; Srivastava, S. K.; Fleming, T. P.; Ron, D.; Eva, A.

In: Oncogene, Vol. 4, No. 6, 1989, p. 767-771.

Research output: Contribution to journalArticle

Ruggiero, M. ; Srivastava, S. K. ; Fleming, T. P. ; Ron, D. ; Eva, A. / NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors : Effect on inositol lipid turnover. In: Oncogene. 1989 ; Vol. 4, No. 6. pp. 767-771.
@article{175464245aa944d5baf038845045f27e,
title = "NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors: Effect on inositol lipid turnover",
abstract = "We have examined polyphosphoinositide turnover in mouse fibroblasts (NIH3T3) transformed by the dbl oncogene as compared to normal cells. The dbl-transformed fibroblasts did not show alterations of the basal level of inositol polyphosphates, polyphosphoinositides, diacylglycerol or phosphatidic acid. This indicates that the activity of C-type phospholipases, inositol lipid kinases and diacylglycerol kinase is not altered in dbl-induced transformation. However, dbl-transformed NIH3T3 cells exhibited increased inositol lipid turnover in response to bradykinin. Further analysis revealed significantly higher number of bradykinin receptors in dbl transfectants as compared to control NIH3T3. When several clonally-derived dbl NIH3T3 transfectants were analyzed, we observed a large variation of their bradykinin receptor number. Cell lines exhibiting increased bradykinin binding, however, failed to show augmented mitogenic response to the peptide agonist. Among other oncogenes, only ras showed a similar effect. We conclude that increased bradykinin receptor number is a phenomenon observed with several cell lines transformed by different oncogenes, and it does not correlate with either enhanced mitogenic responsiveness of transformed cells to the peptide, or with the presence of a specific oncogene in the transformant.",
author = "M. Ruggiero and Srivastava, {S. K.} and Fleming, {T. P.} and D. Ron and A. Eva",
year = "1989",
language = "English",
volume = "4",
pages = "767--771",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors

T2 - Effect on inositol lipid turnover

AU - Ruggiero, M.

AU - Srivastava, S. K.

AU - Fleming, T. P.

AU - Ron, D.

AU - Eva, A.

PY - 1989

Y1 - 1989

N2 - We have examined polyphosphoinositide turnover in mouse fibroblasts (NIH3T3) transformed by the dbl oncogene as compared to normal cells. The dbl-transformed fibroblasts did not show alterations of the basal level of inositol polyphosphates, polyphosphoinositides, diacylglycerol or phosphatidic acid. This indicates that the activity of C-type phospholipases, inositol lipid kinases and diacylglycerol kinase is not altered in dbl-induced transformation. However, dbl-transformed NIH3T3 cells exhibited increased inositol lipid turnover in response to bradykinin. Further analysis revealed significantly higher number of bradykinin receptors in dbl transfectants as compared to control NIH3T3. When several clonally-derived dbl NIH3T3 transfectants were analyzed, we observed a large variation of their bradykinin receptor number. Cell lines exhibiting increased bradykinin binding, however, failed to show augmented mitogenic response to the peptide agonist. Among other oncogenes, only ras showed a similar effect. We conclude that increased bradykinin receptor number is a phenomenon observed with several cell lines transformed by different oncogenes, and it does not correlate with either enhanced mitogenic responsiveness of transformed cells to the peptide, or with the presence of a specific oncogene in the transformant.

AB - We have examined polyphosphoinositide turnover in mouse fibroblasts (NIH3T3) transformed by the dbl oncogene as compared to normal cells. The dbl-transformed fibroblasts did not show alterations of the basal level of inositol polyphosphates, polyphosphoinositides, diacylglycerol or phosphatidic acid. This indicates that the activity of C-type phospholipases, inositol lipid kinases and diacylglycerol kinase is not altered in dbl-induced transformation. However, dbl-transformed NIH3T3 cells exhibited increased inositol lipid turnover in response to bradykinin. Further analysis revealed significantly higher number of bradykinin receptors in dbl transfectants as compared to control NIH3T3. When several clonally-derived dbl NIH3T3 transfectants were analyzed, we observed a large variation of their bradykinin receptor number. Cell lines exhibiting increased bradykinin binding, however, failed to show augmented mitogenic response to the peptide agonist. Among other oncogenes, only ras showed a similar effect. We conclude that increased bradykinin receptor number is a phenomenon observed with several cell lines transformed by different oncogenes, and it does not correlate with either enhanced mitogenic responsiveness of transformed cells to the peptide, or with the presence of a specific oncogene in the transformant.

UR - http://www.scopus.com/inward/record.url?scp=0024314594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024314594&partnerID=8YFLogxK

M3 - Article

C2 - 2543945

AN - SCOPUS:0024314594

VL - 4

SP - 767

EP - 771

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 6

ER -